Resu l ts: Exudative age-related macular degeneration was not observed in 431 patients treated with laser photocoagulation, and was diagnosed in 3.3% of 151 non-laser-treated patients.
Exudative age-related macular degeneration (EAMD) and diabetic retinopathy (DR) are the most frequent sight-threatening diseases of the elderly in the Western world. During the last decades, several authors1-ll have examined the epidemiological aspect of EAMD, but the relation ship between EAMD and DR was poorly docu mented. The aim of this study was to gain more information about the occurrence of EAMD in patients with DR and to evaluate the effect of laser photocoagulation for DR on the development of EAMD. 
PATIENTS AND METHODS
From January 1989 to December 1993 all patients, 55 years or older, with DR who were sent for fundus fluorescein angiography to evaluate DR grade and the need for retinal laser photocoagulation were recruited from the outpatient clinics of the Shaare Zedek Medical Center in Jerusalem and of the Kaplan Hospital in Rehovot. For each patient, a standardised protocol was completed, giving detailed demographic and clinical information including duration of diabetes mellitus, presence of other systemic diseases and medication used. Eye exam ination included best corrected visual acuity, refrac tion, applanation tonometry, biomicroscopy, indirect ophthalmoscopy and Goldmann three-mirror exam ination, colour fundus photography and fluorescein angiography (five 60° fields). In each centre only one retinal specialist (R.Z., A.P.) evaluated the photo graphs. Patients with associated macular pathology secondary to other retinal diseases such as retinal branch vein occlusion, high myopia and other were excluded.
The patients were classified into two main groups: laser-treated DR patients and non-laser-treated DR patients. Laser treatment was done according to the guidelines of the Diabetic Retinopathy Study (DRS) !2 and the recommendations of the Early Treatment Diabetic Retinopathy Study (ETDRS),n Each main group was subdivided into non-prolifera tive diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) subgroups. Patients were graded according to the eye with the worse DR at the last visit or at the time of discovery of the EAMD. Concurrently, we searched for the presence of abnormalities related to age-related macular degen eration (AMD): drusen, retinal pigment epithelial Eye (1997) 11, 872-875 © 1997 Royal College of Ophthalmologists (RPE) changes in the macula, geographic atrophy and EAMD. EAMD was defined by one or more of the following: RPE detachment, sensory retinal detachment, presence of subretinal neovascular membrane on the fluorescein angiogram.
RESULTS
Five hundred and eighty-two (582) patients with DR were included (299 men and 283 women). Twenty-six per cent of the diabetic patients (154 patients) were insulin treated (of these, 11 patients had early onset diabetes mellitus) and the other three-quarters of the patients (428 patients) had non-insulin-dependent diabetes mellitus. Forty per cent of patients had systemic hypertension (more than 145 mmHg systolic and/or more than 90 mmHg diastolic).
With aging, frequencies of emmetropia and myopia decreased, while hypermetropia increased from 17% to 37.2%. Glaucoma was noted in 9.42% of patients in the youngest age group and in 12% in the oldest. Four hundred and thirty-one patients (431) were treated with laser photocoagulation for DR complications; 151 patients were not treated by laser (Table I) . Retinal pathology related to AMD was observed in 59 patients (Table II) ; among these, soft drusen and RPE changes were noted in 12 patients in the non-laser-treated group (8.6%) and in 13 patients in the laser-treated group (2.8%). Five patients (3.3 %) of the non-laser-treated group developed EAMD but none in the laser-treated group (chi-squared = 14.39, one degree of freedom, p<0.0005). Two patients had bilateral EAMD. In 6 eyes a well-defined choroidal neovascular membrane was present. In one eye there was a pigment epithelium detachment (PED). Data on 5 patients in whom we found EAMD are given in Table III .
DISCUSSION
In our study the prevalence of EAMD in patients with DR was only 0.86%. This prevalence is lower than the prevalence of EAMD in the general population as published in the Framingham Eye Study (1.5%),14 in Vinding's study in Copenhagen (2.1 %),15 and in the Beaver Dam Study (1.2%). 16 There is controversy in the literature concerning the prevalence of EAMD among DR patients. Gass,l when searching for the aetiology of AMD, found only one patient with DR in a group of 150 patients with EAMD. In the Framingham Eye Study1 4 this association was present in one eye among 5253 examined eyes. A relative rarity of EAMD in DR patients was also remarked by Benson et alP However, Klein et al. 16 in the Beaver Dam study observed that in people 65 years or older, the prevalence of EAMD was 2.3% in 1704 non diabetics, 5% in 142 diabetics without DR and 3.4% in 83 diabetic patients with DR. Klein et al, did not separate the laser-treated DR patients from the non-laser-treated in their 83 DR patients. They concluded that there was no statistically significant relationship between EAMD and DR. In our study the prevalence of EAMD in all DR patients was as low as 0.86%. However, when we distinguished between laser-treated and non-laser-treated DR patients we found a prevalence of 3.3% among 151 non-Iaser-treated DR patients. Our results among the non-laser-treated DR patients are similar to those published by Klein et al. among 88 patients with DR. In contrast none of our 431 laser-treated DR patients developed EAMD. Drusen and RPE alterations were less frequent in the laser-treated group than in the non-Iaser-treated group.
Understanding the reasons that govern the low prevalence of AMD in DR is difficult. The early signs of AMD are drusen, which are debris observed in Bruch's membrane. They are supposed to result from the metabolic activity of the external retinal la�er and RPE,18,19 or from the choroidal circulation, 2 , 2 1 or both. DR is mainly a microangiopathy of the NLT, non-laser-treated group; LT, laser-treated group; RPE, retinal pigment epithelium; EAMD, exudative age-related macular degeneration. retinal and choroidal vasculature. In the retina, there is a progressive thickening of the basement mem brane of the retinal capillary wall, the sequelae of which are retinal oedema and ischaemia. The diabetic choroidal vasculature is characterised by narrowing of the capillary lumen, with thickening of the basement membrane of the choriocapillary walls, loss of pericytes and proliferation of endothelial cells.
At an advanced stage, capillary drop-out and focal scarring occur? 2 , 23 AMD and DR involve the sensory retina, RPE, Bruch's membrane and chor oid. A possible explanation of the relation between AMD and DR is that the alteration of the metabolic activity of the retina, RPE and vascular choroidal compromise over the years may diminish the production of debris that accumulates in Bruch's membrane and forms drusen. Another possible explanation is that the advanced alteration in the choroidal vascular bed and the modified structure of Bruch's membrane in severe DR may interfere with the deposition of drusen resulting in arrest of the progress to EAMD. It seems that the more advanced the DR, the more pronounced is the prevention of AMD. DR, by definition, was more advanced in the laser-treated group than in the non-laser-treated group, and this may explain why drusen and RPE alterations were less frequent in the laser-treated group (2.8%) than in the non-laser-treated group (8.6%). The complete absence of EAMD among the laser treated DR group may also be explained by the effect of laser photocoagulation on the retina. Retinal laser photocoagulation has been shown to be associated with the disappearance of drusen.1, 24-27 Duvall and Ts0 2 4 have shown experimentally that exposure of drusen to a mild laser burn was followed by dissolution of drusen. They suggested that two kinds of phagocytic cells induced by a local inflam matory reaction removed the extracellular material accumulated in Bruch's membrane. Laser photocoa gulation in DR may induce this local inflammatory reaction. Through this mechanism, the evolution of AMD and development of choroidal neovascularisa tion may be partially blocked. Further studies are needed to better understand the mechanisms involved. Our study suggests that patients with DR who were treated by retinal laser photocoagulation are less prone to develop the exudative form of AMD and this may support indirect evidence of the beneficial effect of laser photocoagulation in halting progression of EAMD.
